January 21, 2021 -- Science 37 has launched a partnership program called Science 37 Certified, which is designed to empower contract research organizations (CROs) with access, training, and commercial support required to deliver decentralized clinical studies for pharmaceutical sponsors.
The program leverages Science 37's operating system to address the expanding decentralized clinical trial market. As part of the program, CROs will be trained on Science 37's Decentralized Clinical Trial Operating System and will have access to the company's Metasite or virtual study arm for any study they are working on. CROs can also access Science 37's decentralized clinical trial investigator network, in-house mobile nurse capability, top-tier patient recruitment strategies, and consulting services.
"As the clinical trial model becomes more dependent on decentralized methodologies to connect patients and providers, many CROs need to rapidly bolster their operations accordingly to compete," said David Coman, CEO of Science 37. "As the leader in decentralized clinical trials, we've built the most advanced operating system of technology and services to enable decentralization. Now we've made it easy for CROs to plug into our operating system for a more complete value proposition."
Copyright © 2021 scienceboard.net